In the colonic mucosa, estrogen can selectively activate ESR2-mediated regulation of mismatch repair proteins, and pro-apoptotic signaling, and can modulate the inflammatory tumor microenvironment and various immune surveillance mechanisms, thereby exerting anti-tumor effects. The gene discussed is ESR2; the disease is neoplasm.